Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,787	5,280	3,348	2,186	2,097	3,039
Market Cap Growth	57.69%	57.69%	53.13%	4.24%	-30.98%	119.78%
Enterprise Value	5,191	4,739	2,933	1,787	1,603	2,598
Last Close Price	54.85	50.39	32.48	20.31	19.80	26.16
PE Ratio	44.59	37.78	31.74	21.59	18.64	28.67
Forward PE	28.72	32.11	32.61	19.95	21.01	32.91
PS Ratio	8.39	7.82	6.94	5.44	5.73	8.59
PB Ratio	8.48	7.77	6.61	4.36	5.58	5.81
P/TBV Ratio	7.77	7.77	6.61	4.36	5.58	5.81
P/FCF Ratio	29.54	26.95	26.38	18.23	12.53	20.16
P/OCF Ratio	29.22	26.66	26.35	18.17	12.49	20.00
PEG Ratio	-	-	-	-	1.50	-
EV/Sales Ratio	7.69	7.02	6.08	4.45	4.38	7.34
EV/EBITDA Ratio	37.68	34.40	27.08	15.69	12.73	20.18
EV/EBIT Ratio	37.90	34.60	27.34	15.86	12.88	20.26
EV/FCF Ratio	26.50	24.19	23.12	14.90	9.58	17.24
Debt / Equity Ratio	0.01	0.01	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.05	0.05	0.00	0.01	0.00	0.02
Debt / FCF Ratio	0.04	0.04	0.00	0.01	0.00	0.02
Asset Turnover	0.92	0.92	0.80	0.80	0.74	0.72
Inventory Turnover	1.08	1.08	0.94	0.97	1.07	1.08
Quick Ratio	3.11	3.11	4.05	6.60	5.31	9.86
Current Ratio	3.35	3.35	4.39	6.89	5.60	10.07
Return on Equity (ROE)	23.81%	23.81%	21.05%	23.11%	25.03%	23.70%
Return on Assets (ROA)	11.71%	11.71%	11.13%	13.98%	15.63%	16.29%
Return on Capital (ROIC)	14.34%	14.34%	13.28%	16.01%	17.25%	17.80%
Return on Capital Employed (ROCE)	19.57%	19.57%	20.75%	22.04%	33.09%	24.45%
Earnings Yield	2.41%	2.67%	3.17%	4.64%	5.36%	3.49%
FCF Yield	3.39%	3.71%	3.79%	5.48%	7.98%	4.96%
Buyback Yield / Dilution	-1.56%	-1.56%	3.64%	7.94%	-1.42%	-1.33%
Total Shareholder Return	-1.56%	-1.56%	3.64%	7.94%	-1.42%	-1.33%

Source: S&P Capital IQ. Standard template. Financial Sources.